Literature DB >> 9543563

The management of osteoporosis-related fractures: a survey of orthopaedic surgeons' practice.

B Pal1, J Morris, B Muddu.   

Abstract

A questionnaire survey of 70 orthopaedic surgeons regarding their policy for the management of osteoporosis-related fractures revealed that, in the main, UK Department of Health guidelines on osteoporosis are not followed uniformly, although Royal College of Physicians guidelines regarding rehabilitation are met more frequently. A written policy or agreed protocol with an osteoporosis service may potentially benefit a large number of patients and reduce future fracture risks.

Entities:  

Mesh：

Year:  1998        PMID： 9543563

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


  5 in total

Review 1.  Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review.

Authors:  V Elliot-Gibson; E R Bogoch; S A Jamal; D E Beaton
Journal:  Osteoporos Int       Date:  2004-07-16       Impact factor: 4.507

2.  A systematic review of the effectiveness of interventions to improve post-fracture investigation and management of patients at risk of osteoporosis.

Authors:  Elizabeth A Little; Martin P Eccles
Journal:  Implement Sci       Date:  2010-10-22       Impact factor: 7.327

3.  The orthopaedic surgeon's role in diagnosing and treating patients with osteoporotic fractures: standing discharge orders may be the solution for timely medical care.

Authors:  John G Skedros
Journal:  Osteoporos Int       Date:  2003-12-16       Impact factor: 4.507

4.  Japanese orthopedists' interests in prevention of fractures in the elderly from falls.

Authors:  Atsushi Harada; Yasumoto Matsui; Masahi Mizuno; Haruhiko Tokuda; Naoakira Niino; Toshiki Ohta
Journal:  Osteoporos Int       Date:  2004-07       Impact factor: 4.507

5.  Barriers to postfracture osteoporosis care in postmenopausal women.

Authors:  Maria-Teresa Cuddihy
Journal:  J Gen Intern Med       Date:  2003-01       Impact factor: 6.473
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.